Literature DB >> 9927062

Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.

N Puget1, D Stoppa-Lyonnet, O M Sinilnikova, S Pagès, H T Lynch, G M Lenoir, S Mazoyer.   

Abstract

Most previous BRCA1 mutation screening studies conducted on breast cancer families were aimed at identifying mutations in the coding sequence and splice sites. Mutations in the promoter and untranslated regions, and large rearrangements are missed by standard mutation detection strategies. To look specifically for such germ-line mutations in the BRCA1 gene, we have analyzed a series of 27 American and 51 French breast cancer families in which no BRCA1 mutation was identified by classical techniques. No mutations were detected in either the promoter or untranslated regions, and we did not find any deletion of the whole gene. Four families were found to carry distinct deletions. Two of them, probably generated by Alu-mediated homologous recombination, were internal deletions of 3 and 23.8 kb, encompassing exon 15 and exons 8-13, respectively. These alterations both lead to a frameshift in the mutant mRNA and to premature stop codon-mediated mRNA decay. The other two deletions encompass exons 1 and 2. On the basis of previous and present analyses, rearrangements represent 8% (3/37) of all mutations in our set of BRCA1 American families. Consequently, the search for rearrangements appears mandatory in BRCA1 mutation screening studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927062

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

Authors: 
Journal:  Am J Hum Genet       Date:  2000-05-25       Impact factor: 11.025

2.  Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

Authors:  Nadine Puget; Sophie Gad; Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Am J Hum Genet       Date:  2002-03-05       Impact factor: 11.025

3.  BRCA2 T2722R is a deleterious allele that causes exon skipping.

Authors:  James D Fackenthal; Luca Cartegni; Adrian R Krainer; Olufunmilayo I Olopade
Journal:  Am J Hum Genet       Date:  2002-07-19       Impact factor: 11.025

4.  BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.

Authors:  Danièle Muller; Catherine Bonaiti-Pellié; Joseph Abecassis; Dominique Stoppa-Lyonnet; Jean-Pierre Fricker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

5.  Molecular analysis of sister chromatid recombination in mammalian cells.

Authors:  Nadine Puget; Melodie Knowlton; Ralph Scully
Journal:  DNA Repair (Amst)       Date:  2005-02-03

6.  The BRCA1 exon 13 duplication in the Swedish population.

Authors:  Barbara Kremeyer; Maria Soller; Kristina Lagerstedt; Paula Maguire; Sylvie Mazoyer; Margareta Nordling; Jan Wahlström; Annika Lindblom
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

7.  Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers.

Authors:  G Chenevix-Trench; O M Sinilnikova; G Suthers; N Pandeya; S Mazoyer; J F Sambrook; S Goldup; D Goldgar; H T Lynch; G M Lenoir; G Cheetham
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

8.  Increased recombination between active tRNA genes.

Authors:  Matthew J Pratt-Hyatt; Kevin M Kapadia; Thomas E Wilson; David R Engelke
Journal:  DNA Cell Biol       Date:  2006-06       Impact factor: 3.311

Review 9.  Functional assays for BRCA1 and BRCA2.

Authors:  Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Int J Biochem Cell Biol       Date:  2006-08-18       Impact factor: 5.085

10.  Low prevalence of BRCA1 exon rearrangements in familial and young sporadic breast cancer patients.

Authors:  David Ellis; Yogen Patel; Shu C Yau; Shirley V Hodgson; Stephen J Abbs
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.